XV. Multiple Myeloma and Cell Therapy Workshop

For the first time, due to the COVID pandemic, XV. Multiple Myeloma and III Cell Therapy Workshop will be held in a fully online version, and you are all invited!


We are happy to announce the XV. Multiple Myeloma & III. Cell therapy workshop on 12.11.2020 and we would like to invite you to follow the workshop, on 12 November 2020 from 9:30 AM CET at the following YouTube link: https://youtu.be/8WyM-UD0e4g 

Unfortunately, due to the COVID pandemic situation, the regular Multiple Myeloma & Cell Therapy Workshop, which always takes place in the autumn, this year will be held in a fully online version. 

During the session, you can ask questions via the sli.do page, by entering the event code:  myeloma

However, you can join the workshop at any moment, and the workshop will be available even after the event for future viewers.

The program this year will have four major sections: 

  1. Genomics of monoclonal gammopathies

  2. Novel molecular aspects in MM biology and therapy

  3. In vivo models and CD38 in MM

  4. Cell-based therapy section

  5. Here all the details of the conference:

The program :

9:30 – 9:40
R.Hájek / M.Šimíček
Introduction


Genomics of monoclonal gammopathies


9:45 – 10:00
M.Zátopková
Genomics of minimal residual disease in MM
10:05 – 10:25


D.Žihala
Genomics in MM extramedullary disease
 
10:30 - 11:00 Break


 
Novel molecular aspects in MM biology and therapy


11:00 – 11:20
A.Vdovin
Proteasome inhibitor resistence in MM: a lesson from imunoglobulin synthesis


11:25 – 11:35
R.Šnaurová
Novel factors regulating Ig production in plasma cells


11:40 – 11:55
M.Turi
Analysis of MyD88 signalosome driving human lymphomas
 
12:00 - 13:00 Break
 


In vivo models and CD38 in MM


13:00 – 13:15
M.Hrdinka
Mouse models in hematooncology


13:20 – 13:35
H.Šahinbegović
Many aspects of CD38 targetability in MM


13:40 – 13:55
T.Jelínek
Daratumumab in MM extramedullary disease
 
14:00 - 14:30 Break
 


Cell-based therapy section


14:30 – 14:45
P. Celichowski
Immunotherapy with universal T cells


14:50 – 15:05
B.Motais
Allogeneic NK cells for cancer treatment


15:10 – 15:25
I.Demel
NK cell therapy - results of clinical trials


15:30 – 15:45
T.Ševčíková
Follow-up ALA genomics project - review and project design


15:50-16:05
B.Wingham (IsoPlexis)
Functional Immune Phenotyping


16:10 – 16:30
Open discussion


16:35 – 16:40
R.Hájek / M.Šimíček
Concluding remarks

We are looking forward to a virtual meeting with you!

 

Professional guarantor of the program:
RNDr. Michal Simicek, PhD. 

 
Seminar secretariat:
HANZO PRODUCTION, SPOL. s ro
Jan Lapes
mobile: +420 734 338 328
email: lapes@hanzo.cz

 

 

Workshop partners

Celgene Janssen Spadia

 

 

 

12.10.2020


Back